A Clinical Study of Cizutamig in Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Thyroid Eye Disease, TED

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Ninth People's hospital Shanghai Jiaotong University school of medicines, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Huifang Zhou, Ph.D) · fangzzfang@sjtu.edu.cn · +86 13661901886
Contact: Study coordinator (Lina Xing, Ph.D) · jygcp666@126.com · +86 13918035850

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Little Rock, United States · Newport Beach, United States

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy · Graves Orbitopathy

Abroad (travel likely)RecruitingPHASE2

Xiamen, China

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy

Abroad (travel likely)Recruiting

Taipei, Taiwan

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Thyroid Eye Disease · Graves Orbitopathy · Endocrine System Diseases

Abroad (travel likely)RecruitingPHASE2, PHASE3

Miami, United States · Morgantown, United States